Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.50 |
| ▸ | CCR5 | P51681 | 3/20 | 0.50 |
| ▸ | CCR8 | P51685 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ALPL | P05186 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.48 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17899680 | 1.00 | CCR1 (0.50) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL31344366 | 0.94 | CCR1 (0.47) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL12131380 | 0.92 | CCR1 (0.51) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL27254824 | 0.87 | CYP1A2 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL30930810 | 0.87 | CYP1A2 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL7790789 | 0.84 | CYP2D6 (0.67) | CCR1CCR5CCR8KDM4ELMNA | |
| 2-Mercaptoethanol SCHEMBL7795196 | 0.83 | CYP2D6 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL8617860 | 0.82 | CCR1 (0.51) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL13596182 | 0.82 | CYP1A2 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL12131435 | 0.82 | LTB4R (0.49) | CCR1CCR5CCR8KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4634168-A1 | TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS | Johnson & Johnson Vision Care, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| CN-118745263-A | Surface modified carbon fiber reinforced polyether-ether-ketone composite material and preparation method thereof | 吉林大学 | 2024-10-08 | — | — | CN | disclosed |
| US-20240228466-A1 | TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS | JOHNSON & JOHNSON VISION CARE, INC. | 2024-07-11 | — | — | US | disclosed |
| WO-2024127114-A1 | TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228466-A1 | TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS | UACA, C1R, MSH2 | CCR1 2045/4885CCR5 3276/4885CCR8 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.